Structure

(2R,4S)-3-tert-Butyl 4-methyl 2-tert-butyloxazolidine-3,4-dicarboxylate

CAS
145625-08-7
Catalog Number
ACM145625087
Category
Other Products
Molecular Weight
287.35
Molecular Formula
C14H25NO5

If you have any other questions or need other size, please get a quote.

  • Product Description
  • Case Study
  • Custom Reviews
  • Custom Q&A
  • Synthetic Use
  • Related Resources

Upstream Synthesis Route 1

  • 24424-99-5
  • 190080-34-3
  • 145625-08-7

Reference: [1]Cagnon, Jose Renato; Le Bideau, Franck; Marchand-Brynaert, Jacqueline; Ghosez, Leon
[Tetrahedron Letters, 1997, vol. 38, # 13, p. 2291 - 2294]
[2]Fairhurst, Nathan W. G.; Mahon, Mary F.; Munday, Rachel H.; Carbery, David R.
[Organic Letters, 2012, vol. 14, # 3, p. 756 - 759]
[3]Zhang, Xiao; King-Smith, Emma; Renata, Hans
[Angewandte Chemie - International Edition, 2018, vol. 57, # 18, p. 5037 - 5041][Angew. Chem., 2018, vol. 130, # 18, p. 5131 - 5135,5]
[4]Current Patent Assignee: GENFLEET THERAPEUTICS SHANGHAI; ZHEJIANG GENFLEET THERAPEUTICS - WO2022/63101, 2022, A1
Location in patent: Page/Page column 72

Downstream Synthesis Route 1

  • 145625-08-7
  • 190080-35-4

Reference: [1]Cagnon, Jose Renato; Le Bideau, Franck; Marchand-Brynaert, Jacqueline; Ghosez, Leon
[Tetrahedron Letters, 1997, vol. 38, # 13, p. 2291 - 2294]
[2]Ghosez, Léon; Yang, Gaoqiang; Cagnon, José Renato; Bideau, Franck Le; Marchand-Brynaert, Jacqueline
[Tetrahedron, 2004, vol. 60, # 35, p. 7591 - 7606]
[3]Fairhurst, Nathan W. G.; Mahon, Mary F.; Munday, Rachel H.; Carbery, David R.
[Organic Letters, 2012, vol. 14, # 3, p. 756 - 759]

* For details of the synthesis route, please refer to the original source to ensure accuracy.

Please kindly note that our products are for research use only.

Alfa Chemistry

For product inquiries, please use our online system or send an email to .

Alfa Chemistry
Shopping basket
Loading...
Loading...
Download PDF documentDownload
* I hereby give my consent that I may receive marketing e-mails with information on existing and new services from this company. I know that I can opt-out from receiving such e-mails at any time or by using the link which will be provided in each marketing e-mail.